Search

everythinglearnresearchcommunity

for

Search:↓

Mood stabilizers like lithium and anticonvulsants have side effects that can lead to patients stopping their medication, and managing these effects is important for treatment adherence.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Oral minoxidil promotes hair growth but may cause side effects; needs monitoring.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

Cathepsin L is essential for heart health and its absence causes heart problems and hair loss.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Hair loss links to higher death risk from diabetes and heart disease; not a direct cause, but a marker for risk factors.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Premature graying of hair may suggest health issues and currently lacks effective treatments.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Vitamin D and its receptor are essential for hair growth, cell regulation, immune function, and heart health.

Minoxidil causes excessive hair growth in almost all patients.

Stress from being transgender is linked to higher blood pressure at night and more inflammation, which may affect heart health.

Minoxidil lowers blood pressure, increases heart rate, and improves blood flow in dogs.

Severe vertex pattern hair loss may indicate a higher risk for artery plaque buildup.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

People with early onset baldness have higher bad cholesterol and lower good cholesterol, increasing their heart disease risk.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

Gender-affirming hormone therapy affects health risks and requires careful management, especially as transgender individuals age.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

Polycystic Ovary Syndrome (PCOS) is common in women with conditions like anovulation, hirsutism, hair loss, and type 2 diabetes, and it can lead to health risks like heart disease, obesity, insulin resistance, and depression. Non-Classic Congenital Adrenal Hyperplasia (NC-CAH) is also discussed.